0001567619-22-013139.txt : 20220617 0001567619-22-013139.hdr.sgml : 20220617 20220617212734 ACCESSION NUMBER: 0001567619-22-013139 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220615 FILED AS OF DATE: 20220617 DATE AS OF CHANGE: 20220617 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Grais Linda CENTRAL INDEX KEY: 0001413306 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37719 FILM NUMBER: 221025770 MAIL ADDRESS: STREET 1: 86 ALEJANDRA AVE CITY: ATHERTON STATE: CA ZIP: 94027 FORMER NAME: FORMER CONFORMED NAME: Grais Linda S DATE OF NAME CHANGE: 20070924 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Corvus Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001626971 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 464670809 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 863 MITTEN ROAD STREET 2: SUITE 102 CITY: BURLINGAME STATE: CA ZIP: 94010 BUSINESS PHONE: (650) 900-4520 MAIL ADDRESS: STREET 1: 863 MITTEN ROAD STREET 2: SUITE 102 CITY: BURLINGAME STATE: CA ZIP: 94010 4 1 doc1.xml FORM 4 X0306 4 2022-06-15 0 0001626971 Corvus Pharmaceuticals, Inc. CRVS 0001413306 Grais Linda C/O CORVUS PHARMACEUTICALS, INC. 863 MITTEN ROAD, SUITE 102 BURLINGAME CA 94010 1 0 0 0 Stock Option (Right to Buy) 0.9899 2022-06-15 4 A 0 15000 0.00 A 2032-06-15 Common Stock 15000 15000 D The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the first anniversary of the grant date or (ii) the date of the 2023 Annual Meeting of the Issuer's stockholders, assuming continuous service as a director until such vesting date. /s/ Leiv Lea, as Attorney-in-Fact for Linda S. Grais 2022-06-17